Jon Kessler Sells 33,765 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

HealthEquity Trading Up 0.3 %

HQY opened at $79.72 on Thursday. The business has a 50 day simple moving average of $79.76 and a two-hundred day simple moving average of $73.25. The firm has a market capitalization of $6.84 billion, a price-to-earnings ratio of 124.56, a PEG ratio of 1.34 and a beta of 0.53. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.93. HealthEquity, Inc. has a one year low of $48.86 and a one year high of $84.49.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. JPMorgan Chase & Co. cut their price objective on HealthEquity from $81.00 to $73.00 and set an “overweight” rating for the company in a report on Friday, December 1st. Royal Bank of Canada boosted their target price on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, March 20th. BTIG Research boosted their target price on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Barrington Research reissued an “outperform” rating and issued a $100.00 target price on shares of HealthEquity in a research note on Friday, March 22nd. Finally, Raymond James boosted their target price on HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 13th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.55.

Get Our Latest Research Report on HealthEquity

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC grew its stake in shares of HealthEquity by 4.7% in the 4th quarter. Janney Montgomery Scott LLC now owns 3,115 shares of the company’s stock worth $207,000 after buying an additional 140 shares during the last quarter. Xponance Inc. lifted its holdings in shares of HealthEquity by 1.2% during the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock valued at $813,000 after buying an additional 147 shares during the period. O Shaughnessy Asset Management LLC lifted its holdings in shares of HealthEquity by 3.3% during the 2nd quarter. O Shaughnessy Asset Management LLC now owns 5,060 shares of the company’s stock valued at $319,000 after buying an additional 160 shares during the period. Fifth Third Bancorp lifted its holdings in shares of HealthEquity by 36.5% during the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after buying an additional 161 shares during the period. Finally, Metropolitan Life Insurance Co NY lifted its holdings in shares of HealthEquity by 3.6% during the 4th quarter. Metropolitan Life Insurance Co NY now owns 5,190 shares of the company’s stock valued at $320,000 after buying an additional 179 shares during the period. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.